Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAPPORT: Telithromycin vs Azithromycin vs Clarithromycin in Respiratory Infections
NCT00245453Phase 4Withdrawn
- Sponsor
- CPL Associates
- Start
- Oct 2005
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of telithromycin in community acquired pneumonia (CAP), chronic bronchitis (CB), sponsored by CPL Associates. Planned start Oct 2005; status: withdrawn.
02
Drugs
telithromycin
03
Conditions
community acquired pneumonia (CAP)chronic bronchitis (CB)
Beyond the preview
Go deeper on NCT00245453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00245453.